Delivery Order SPE2DB22D1103-SPE2DB24FTFT8
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 4563849287 capsules in 100-count packages. The potential value of this contract is $1,366.89 with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $1,835.43 firm fixed price delivery order to supply 24,000 units of the pharmaceutical product CREON DR 100S capsules. The delivery order, which has a completion date of January 2, 2024, was awarded on December 29, 2023 and is to be performed at Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a prime contractor that has...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR. The $2,458.62 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 36,000 units of CREON DR 36,000 UNIT CAPSULE 100S. The $4,679.82 delivery order has a completion date of December 21, 2023. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor for this pharmaceutical supply delivery order, which has no set-aside designation. The company has...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 100s capsules. The $10,018.28 award has a completion date of January 24, 2024. Amerisourcebergen Drug Corp is a prime contractor that previously received indefinite delivery contracts from DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation to supply pharmaceuticals,...
- The U.S. Defense Logistics Agency (DLA) awarded a $98,647.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 24,000 units of the pharmaceutical product CREON DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is not subject to any set-aside designation. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 24,000 units of the pharmaceutical product Creon DR in 100-count capsule bottles. The $8,452.28 contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 that serves as the primary...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit organization, a firm fixed price delivery order contract valued at $8,347.84 to supply 36,000 units of the 100-count capsule product CREON DR. The contract, which does not have a set-aside designation, has a performance period ending on March 5, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is a subsidiary of the global pharmaceutical sourcing and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $7,182.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, which has an ultimate completion date of April 3, 2024, is for the delivery of 36,000 unit capsules of the medication CREON DR 100s. This delivery order was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded solely to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,507.01 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR 100s. The contract has a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is associated with a larger indefinite...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTFT8Delivery Order
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide 36,000 units of the prescription medication CREON DR in 100-count capsule bottles. The contract has a total potential value of $1,171.68 and a completion date of February 29, 2024. This delivery order contract is not associated with any larger contract vehicles and was awarded directly to Amerisourcebergen Drug Corp without any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor responsible for supplying these pharmaceutical products to support military treatment programs and facilities under the purview of the DLA Troop Support Medical.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 2/28/24 |